VTE Incidence After Rivaroxaban + Aspirin or SAPT After Lower-limb Revascularization
type: MedicalStudy
description: Incidence of Venous Thromboembolism After Lower Limb Revascularization in Patients Receiving Rivaroxaban 2.5 Mg Bid + Aspirin 100 Mg Versus Single Antiplatelet Treatment - a Randomized Clinical Trial
status: RECRUITING
study design: INTERVENTIONAL
phase: PHASE4
start date: 2024-02-24
end date: 2025-07-30
license: https://creativecommons.org/publicdomain/zero/1.0/
source: https://clinicaltrials.gov/study/NCT06873321
source organization: US National Library of Medicine
publisher: AI Analytics
sponsor: Science Valley Research Institute
study subject: Peripheral Arterial Disease
study subject: Venous Thormboembolism
study subject: Cardiovascular Diseases
study subject: Vascular Surgery Patient with PAD / Carotid Stenosis
keywords: PHASE4
keywords: INTERVENTIONAL
keywords: RECRUITING
keywords: Peripheral Arterial Disease
keywords: Venous Thormboembolism
keywords: Cardiovascular Diseases
keywords: Vascular Surgery Patient with PAD / Carotid Stenosis

AI Analytics
type: Organization